AVR 0.06% $15.71 anteris technologies ltd

Anteris Channel 9 Interview 2022, page-33

  1. 4,771 Posts.
    lightbulb Created with Sketch. 273
    In my case, partly because my daughter is a GP, probably because of her input we received a lot more information than most patients. Because of my condition, endocarditis and a growth on the valve, a surgical procedure was opted for in preference to TAVR. The cardiac team informed me that the valve should last 10-20 years before requiring replacement. At a point where it does deteriorate sufficiently to require replacement a TAVR procedure, valve in valve, is the most likely option. Regular echos monitor the valves performance.
    I've attached a peer reviewed paper to support my comments. Again, please correct me if I've posted anything untrue.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994436/
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.71
Change
0.010(0.06%)
Mkt cap ! $301.9M
Open High Low Value Volume
$16.00 $16.01 $15.49 $3.254M 230.5K

Buyers (Bids)

No. Vol. Price($)
1 100 $15.70
 

Sellers (Offers)

Price($) Vol. No.
$16.20 700 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.